RobertScottSvatekMD
Urology • San Antonio, TXProfessor and Chair, Urology, University of Texas Medical School, San Antonio
Dr. Svatek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8300 Floyd Curl Drive
4th Floor -4B
San Antonio, TX 78229Phone+1 210-450-9600Fax+1 210-450-9656
Education & Training
University of Texas Southwestern Medical CenterResidency, Urology, 2003 - 2007
University of Texas M D Anderson Cancer CenterInternship, Transitional Year, 2002 - 2003
University of Texas Medical Branch School of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2004 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
- S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer Start of enrollment: 2011 Nov 25
- A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer Start of enrollment: 2016 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 349 citationsThe Economics of Bladder Cancer: Costs and Considerations of Caring for This DiseaseRobert S. Svatek, Brent K. Hollenbeck, Sten Holmäng, Richard K. Lee, Simon P. Kim
European Urology. 2014-08-01 - 44 citationsConsiderations for successful cancer immunotherapy in aged hostsVincent Hurez, Alvaro Padron, Robert S. Svatek, Tyler J. Curiel
Clinical and Experimental Immunology. 2016-11-07 - 20 citationsRole of immunotherapy in bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancerNeelam Mukherjee, Robert S. Svatek, Ahmed M. Mansour
Urologic Oncology. 2018-02-09
Press Mentions
Modified Bladder Cancer Treatment Shows Promise in Animal StudiesAugust 23rd, 2022- Bladder Cancer Is More Aggressive and Advanced in South Texas, Study ShowsFebruary 25th, 2021
- New Data Analyses from Phase 3 Study of Investigational Gene Therapy Nadofaragene Firadenovec Presented at Society of Urologic Oncology Annual Meeting Adds More Evidence to Data Published in Lancet OncologyDecember 2nd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
